Actively Recruiting
Home Treatment for Individuals Suffering From Severe Addictive Disorders
Led by Louise Penzenstadler · Updated on 2025-08-28
40
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted. The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.
CONDITIONS
Official Title
Home Treatment for Individuals Suffering From Severe Addictive Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Substance use disorder
- Age 18 or above
- Sufficient French language skills
- Competent subjects
- Consent to randomization process
You will not qualify if you...
- Organic brain disease or developmental disorder
- Non-voluntary admission
- Severe somatic comorbidity
- History of complicated substance withdrawal
- Acute suicidal ideation
- Aggressive behavior
- Acute psychiatric disease such as mania or psychosis
- Distance to center must allow reach within 60 minutes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Geneva University Hospital
Geneva, Switzerland
Actively Recruiting
Research Team
L
Louise Penzenstadler, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here